Informationen:
Fehler:
ID
33291
Beschreibung
Vernakalant Versus Flecainide: Atrial Contractility; ODM derived from: https://clinicaltrials.gov/show/NCT01646281
Link
https://clinicaltrials.gov/show/NCT01646281
Stichworte
Versionen (1)
- 04.12.18 04.12.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
4. Dezember 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Atrial Fibrillation NCT01646281
Eligibility Atrial Fibrillation NCT01646281
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Atrial Fibrillation NCT01646281
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Persistent atrial fibrillation | Paroxysmal atrial fibrillation
Item
persistent af or paroxysmal af
boolean
C2585653 (UMLS CUI [1])
C0235480 (UMLS CUI [2])
C0235480 (UMLS CUI [2])
Vernakalant Infusion | Flecainide Infusion | Sinus rhythm Restore
Item
eligible for treatment with vernakalant or flecainide infusion to restore sinus rhythm
boolean
C2001572 (UMLS CUI [1,1])
C0574032 (UMLS CUI [1,2])
C0016229 (UMLS CUI [2,1])
C0574032 (UMLS CUI [2,2])
C0232201 (UMLS CUI [3,1])
C1283255 (UMLS CUI [3,2])
C0574032 (UMLS CUI [1,2])
C0016229 (UMLS CUI [2,1])
C0574032 (UMLS CUI [2,2])
C0232201 (UMLS CUI [3,1])
C1283255 (UMLS CUI [3,2])
Anticoagulant therapy | Atrial Fibrillation Episode Duration
Item
receiving adequate anticoagulant therapy (or having an episode of af lasting < 24 hours)
boolean
C0150457 (UMLS CUI [1])
C0004238 (UMLS CUI [2,1])
C0332189 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0004238 (UMLS CUI [2,1])
C0332189 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Informed Consent Refused | Informed Consent Unable
Item
refusal or inability to give informed consent to participate in this study
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
C1705116 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Atrial Flutter
Item
atrial flutter
boolean
C0004239 (UMLS CUI [1])
Medical contraindication Vernakalant | Medical contraindication Flecainide
Item
contra-indications for receiving vernakalant or flecainide according to mumc+
boolean
C1301624 (UMLS CUI [1,1])
C2001572 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0016229 (UMLS CUI [2,2])
C2001572 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0016229 (UMLS CUI [2,2])
Hemodynamic instability | LVEF | Potassium level Inadequate | Ischemia | Sinus Node Dysfunction
Item
protocol (unstable hemodynamic condition, lvef < 40%, inadequate potassium levels, acute ischaemia, sinus node dysfunction)
boolean
C0948268 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
C0202194 (UMLS CUI [3,1])
C0205412 (UMLS CUI [3,2])
C0022116 (UMLS CUI [4])
C0428908 (UMLS CUI [5])
C0428772 (UMLS CUI [2])
C0202194 (UMLS CUI [3,1])
C0205412 (UMLS CUI [3,2])
C0022116 (UMLS CUI [4])
C0428908 (UMLS CUI [5])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])